töltés Hosszú időzítő median overall survival for diffuse astrocytoma uralkodik szindróma Elnyel
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy | Journal of Cancer Research and Clinical Oncology
Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors - ScienceDirect
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
Astrocytoma progression scoring system based on the WHO 2016 criteria | Scientific Reports
Advantages of gross total resection in patients with astrocytoma: A population‑based study
Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis - Roux -
Brain Tumour Registry of Canada (BTRC): Survival and Prevalence Report 2010–2017 June 2022
Kaplan–Meier survival curves for all lower-grade glioma and WHO 2016... | Download Scientific Diagram
Frontiers | Prognostic Factors Associated With Survival in Patients With Diffuse Astrocytoma
Predicting overall survival in diffuse glioma from the presurgical connectome | Scientific Reports
Biomedicines | Free Full-Text | The Current State of Adult Glial Tumor Patients’ Care in Kazakhstan: Challenges in Diagnosis and Patterns in Survival Outcomes
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors - Frontiers
Glioma - Wikipedia
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery | Acta Neuropathologica Communications | Full Text
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis | Anticancer Research
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Overall survival of patients with diffuse astrocytomas. The presence of... | Download Scientific Diagram
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram